Lars D. Engstrom
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
Papers in
-
- Cancer-related gene regulation 8
- Ubiquitin and proteasome pathways 3
- Oncology 9
- Cancer Immunotherapy and Biomarkers 3
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- James G. Christensen (18 shared papers)Ruth Aranda (14 shared papers)Peter Olson (13 shared papers)Jill Hallin (12 shared papers)David M. Briere (14 shared papers)Niranjan Sudhakar (6 shared papers)Daniel S. Wechsler (3 shared papers)Andressa L. Sodré (1 shared paper)
- Journals
- Cancer Research (10 papers)Molecular Cancer Therapeutics (6 papers)Molecular Cancer Research (2 papers)Neoplasia (1 paper)The Prostate (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Lars D. Engstrom
20 papers receiving 452 citations
Peers
Comparison fields: 5 of 47
- Oncology 180
- Hepatology 33
- Molecular Biology 277
- Immunology 78
- Cancer Research 46
Countries citing papers authored by Lars D. Engstrom
This map shows the geographic impact of Lars D. Engstrom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars D. Engstrom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars D. Engstrom more than expected).
Fields of papers citing papers by Lars D. Engstrom
This network shows the impact of papers produced by Lars D. Engstrom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars D. Engstrom. The network helps show where Lars D. Engstrom may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars D. Engstrom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 124 | |
| 2 | 2021 | 116 | |
| 3 | 2012 | 58 | |
| 4 | 2001 | 45 | |
| 5 | 2002 | 36 | |
| 6 | 2004 | 18 | |
| 7 | 2021 | 11 | |
| 8 | 2011 | 10 | |
| 9 | 2019 | 10 | |
| 10 | 2022 | 10 | |
| 11 | 2019 | 7 | |
| 12 | 2019 | 6 | |
| 13 | 2024 | 2 | |
| 14 | 2021 | 2 | |
| 15 | 2023 | 1 | |
| 16 | 2020 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2020 | 1 |
About Lars D. Engstrom
Lars D. Engstrom is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Organic Chemistry and Computational Theory and Mathematics, having authored 24 papers that have together received 461 indexed citations. Recurring topics across this work include Cancer-related gene regulation (8 papers), Ferroptosis and cancer prognosis (3 papers), Ubiquitin and proteasome pathways (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Click Chemistry and Applications (2 papers), Cancer Genomics and Diagnostics (2 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Oncology (180 citations), Hepatology (33 citations), Molecular Biology (277 citations), Immunology (78 citations) and Cancer Research (46 citations). Lars D. Engstrom has collaborated with scholars based in United States and Germany. Frequent co-authors include James G. Christensen, Ruth Aranda, Peter Olson, Jill Hallin, David M. Briere, Niranjan Sudhakar, Daniel S. Wechsler, Andressa L. Sodré, Harrah Chiang and David Woods. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Molecular Cancer Research, Neoplasia and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.